Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 14 best booming stocks to buy right now. The company’s shares have ...
Structure Therapeutics recently reported strong Phase 2b results for its oral weight-loss candidate aleniglipron, secured a ...
Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...
Stocktwits on MSN
VKTX, TERN, GPCR shares rally as Novo Nordisk sounds willingness towards portfolio-expansion deals
Viking CEO Brian Lian said at the conference earlier this week that the strategic interest in weight-loss drug deals is ...
As of Tuesday, January 13, Structure Therapeutics Inc.’s GPCR share price has surged by 6.29%, which has investors ...
Fintel on MSN
Structure Therapeutics Inc. - Depositary Receipt (GPCR) price target increased by 10.08% to 103.82
The average one-year price target for Structure Therapeutics Inc. - Depositary Receipt (NasdaqGM:GPCR) has been revised to ...
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies -- Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of ...
A company controlled by the Johnson family sold thousands of shares of this clinical-stage biopharmaceutical company, but ...
The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...
Domain Therapeutics becomes Kainova Therapeutics and advances its clinical pipeline of GPCR-modulating therapies: Montreal, Canada Tuesday, January 13, 2026, 18:00 Hrs [IST] Kaino ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback